AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2013
Nov 21, 2013
29755_dirs_2013-11-21_1c752885-447e-40d1-bc55-909e5a6f7d4c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-11-19
Reporting Person: HURWICH THOMAS A. (VP, Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-19 | Common stock, $0.01 par value | M | 2158 | $24.0731 | Acquired | 52941 | Direct |
| 2013-11-19 | Common stock, $0.01 par value | F | 1063 | $48.87 | Disposed | 51878 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-19 | Option (right to buy) | $24.0731 | M | 2158 | Disposed | 2015-02-17 | Common stock (2158) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 400 | Indirect |
| Common stock, $0.01 par value | 274 | Indirect |
Footnotes
F1: Balance in AbbVie Savings Program as of November 19, 2013.
F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4